Roche schedules October 22 sales update: what it means for Roche Holding stock
Published on 10/17/2026 at 11:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming investor timetable
- Roche scheduled its third-quarter sales update for October 22, 2026.
- The company plans to publish the sales release at 7:00 a.m. CEST.
- The investor webinar is scheduled from 2:00 p.m. to 3:30 p.m. CEST.
Roche scheduled its third-quarter sales update for October 22, 2026, according to an investor-relations notice dated October 15, 2026. The company said it will publish the release before the opening of the Swiss Stock Exchange at 7:00 a.m. CEST. Roche Investor Relations also said presentation slides will be posted on its investor-relations website.
Market context: Market report SMI.
Weekend trading
Roche Holding is covered by a continuously updated real-time quote of Roche Holding stock.
Investor timetable
The sales presentation and webinar are scheduled for October 22, 2026. Roche said the webinar will run from 2:00 p.m. to 3:30 p.m. CEST and will include a presentation followed by a question-and-answer session. The listed presenters are Chief Executive Officer Thomas Schinecker, Chief Financial Officer Alan Hippe, Roche Pharmaceuticals Chief Executive Officer Teresa Graham and Roche Diagnostics Chief Executive Officer Matt Sause. Roche Investor Relations said a replay will be available after the webcast.
Coming date
The next substantiated company date is October 22, 2026, when Roche plans to publish third-quarter sales and hold the investor presentation.
